VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $670,617,000 | +1344.9% | 2,885,617 | -1.0% | 0.55% | +1147.7% |
| Q1 2018 | $46,412,000 | -23.4% | 2,915,297 | +0.0% | 0.04% | -21.4% |
| Q4 2017 | $60,579,000 | +45.0% | 2,915,257 | -0.0% | 0.06% | +40.0% |
| Q3 2017 | $41,789,000 | -17.4% | 2,916,175 | -0.2% | 0.04% | -20.0% |
| Q2 2017 | $50,568,000 | +56.4% | 2,923,017 | -0.3% | 0.05% | +51.5% |
| Q1 2017 | $32,328,000 | -24.1% | 2,930,936 | -0.1% | 0.03% | -29.8% |
| Q4 2016 | $42,581,000 | -40.8% | 2,932,586 | +0.0% | 0.05% | -42.0% |
| Q3 2016 | $71,987,000 | +21.6% | 2,932,246 | -0.3% | 0.08% | +15.7% |
| Q2 2016 | $59,214,000 | -23.4% | 2,940,141 | +0.0% | 0.07% | -23.9% |
| Q1 2016 | $77,318,000 | -75.0% | 2,939,863 | -3.4% | 0.09% | -74.3% |
| Q4 2015 | $309,421,000 | -43.0% | 3,043,982 | -0.0% | 0.36% | -44.9% |
| Q3 2015 | $543,117,000 | -19.7% | 3,044,717 | +0.0% | 0.65% | -9.1% |
| Q2 2015 | $676,373,000 | +11.6% | 3,044,668 | -0.2% | 0.72% | +13.7% |
| Q1 2015 | $606,069,000 | +38.2% | 3,051,398 | -0.4% | 0.63% | +36.4% |
| Q4 2014 | $438,659,000 | +9.8% | 3,065,188 | +0.7% | 0.46% | +4.8% |
| Q3 2014 | $399,362,000 | +4.4% | 3,043,918 | +0.3% | 0.44% | +2.3% |
| Q2 2014 | $382,659,000 | +1.9% | 3,034,090 | +6.5% | 0.43% | -3.6% |
| Q1 2014 | $375,473,000 | +20.1% | 2,848,160 | +6.9% | 0.45% | +14.4% |
| Q4 2013 | $312,745,000 | +33.0% | 2,663,930 | +18.2% | 0.39% | +18.9% |
| Q3 2013 | $235,205,000 | +18.7% | 2,254,430 | -2.0% | 0.33% | +8.6% |
| Q2 2013 | $198,076,000 | – | 2,301,058 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |